Agomab Therapeutics, an Asabys portfolio company, debuts on Nasdaq

by Asabys Partners

The relationship with the company began in 2021, when Agomab acquired Origo Biopharma, one of their portfolio companies, marking Asabys’s first exit. Since then, they have continued to support Agom...

Read more

Para el Nasdaq no hay pandemia

by Solventis CIB

Las FAANG representan alrededor del 20% del Nasdaq y lo están haciendo bastante bien, demostrando que la tecnología es un ganador claro de esta crisis, como se ve por los diferenciales con respecto ...

Read more

Edesa Biotech, participada de Inveready, sale al Nasdaq

by Inveready Asset Management

Edesa Biotech Inc., participada de Inveready, ha firmado un acuerdo de intercambio de acciones con Stellar Biotechnologies, Inc. (Nasdaq: SBOT). Edesa es una compañía Canadiense participada por Inve...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream